Zhang C, Mao Y, Tan Y, Zhang M, Shao K, Wang S
J Transl Autoimmun. 2025; 10:100276.
PMID: 39995790
PMC: 11849641.
DOI: 10.1016/j.jtauto.2025.100276.
Ayub S, Shah Z, Sofi F, Rasool R, Shafi T, Dangroo M
Mediterr J Rheumatol. 2025; 35(4):645-652.
PMID: 39886279
PMC: 11778618.
DOI: 10.31138/mjr.040124.eoi.
Lau L, Cariaga T, Chang A, Lane J, Purtha W, Rapaport A
Nat Commun. 2025; 16(1):968.
PMID: 39856038
PMC: 11760370.
DOI: 10.1038/s41467-024-55690-0.
Huo L, Kumar A, Tumurkhuu G, Bose M, Berman D, Wallace D
Sci Rep. 2025; 15(1):2457.
PMID: 39828802
PMC: 11743764.
DOI: 10.1038/s41598-024-82190-4.
Stockfelt M, Teng Y, Vital E
Nat Rev Rheumatol. 2025; 21(2):111-126.
PMID: 39815102
DOI: 10.1038/s41584-024-01210-9.
Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus.
Goldbach-Mansky R, Alehashemi S, de Jesus A
Nat Rev Rheumatol. 2024; 21(1):22-45.
PMID: 39623155
DOI: 10.1038/s41584-024-01184-8.
Interferon-α as a biomarker to predict renal outcomes in lupus nephritis.
Whittall Garcia L, Gladman D, Urowitz M, Bonilla D, Schneider R, Touma Z
Lupus Sci Med. 2024; 11(2).
PMID: 39613334
PMC: 11605838.
DOI: 10.1136/lupus-2024-001347.
Multiple RNA-binding proteins associated with long interspersed element-1 encoded ORF1p are targeted by the autoimmune response in systemic lupus erythematosus.
Ukadike K, Colyer A, Duvvuri B, Bengtsson A, Taylor M, LaCava J
J Cell Mol Immunol. 2024; 2(1):35-44.
PMID: 39606792
PMC: 11600341.
DOI: 10.46439/immunol.2.022.
Comparison of cell type and disease subset chromatin modifications in SLE.
Beigel K, Wang X, Song L, Maurer K, Breen C, Taylor D
Clin Epigenetics. 2024; 16(1):159.
PMID: 39543716
PMC: 11566291.
DOI: 10.1186/s13148-024-01754-3.
Tofacitinib for child-onset systemic lupus erythematosus.
Hou L, Zhou P, Zhao C, Wang X, Du Y
Front Immunol. 2024; 15:1457821.
PMID: 39439798
PMC: 11493632.
DOI: 10.3389/fimmu.2024.1457821.
The path ahead for understanding Toll-like receptor-driven systemic autoimmunity.
Hamerman J, Barton G
Curr Opin Immunol. 2024; 91:102482.
PMID: 39353255
PMC: 11863706.
DOI: 10.1016/j.coi.2024.102482.
Coordinated, multicellular patterns of transcriptional variation that stratify patient cohorts are revealed by tensor decomposition.
Mitchel J, Gordon M, Perez R, Biederstedt E, Bueno R, Ye C
Nat Biotechnol. 2024; .
PMID: 39313646
DOI: 10.1038/s41587-024-02411-z.
VPS13C and STING expression in neuropsychiatric systemic lupus erythematosus: unveiling an unbreached territory.
Ebaid A, Zakaria M, Mekkawy E, Nageeb R, Elfwakhry R, Seleem D
Lupus Sci Med. 2024; 11(2).
PMID: 39306342
PMC: 11418578.
DOI: 10.1136/lupus-2024-001271.
CD9 and Aryl Hydrocarbon Receptor Are Markers of Human CD19+CD14+ Atypical B Cells and Are Dysregulated in Systemic Lupus Erythematous Disease.
Blevins L, Khan D, Crawford R, ONeill C, Bach A, Zhou J
J Immunol. 2024; 213(8):1076-1092.
PMID: 39212542
PMC: 11458359.
DOI: 10.4049/jimmunol.2400193.
Identification of NET formation and the renoprotective effect of degraded NETs in lupus nephritis.
Jin Y, Wang Y, Ma X, Li H, Zhang M
Am J Physiol Renal Physiol. 2024; 327(4):F637-F654.
PMID: 39205658
PMC: 11483074.
DOI: 10.1152/ajprenal.00122.2024.
Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options.
Drougkas K, Skarlis C, Mavragani C
Mediterr J Rheumatol. 2024; 35(Suppl 2):365-380.
PMID: 39193187
PMC: 11345602.
DOI: 10.31138/mjr.270324.tis.
The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis.
Quan L, Dai J, Luo Y, Wang L, Liu Y, Meng J
Hum Vaccin Immunother. 2024; 20(1):2387461.
PMID: 39149877
PMC: 11328883.
DOI: 10.1080/21645515.2024.2387461.
Sterile activation of RNA-sensing pathways in autoimmunity.
Li J, Zhu J, Yang H, Hou F
J Mol Cell Biol. 2024; 16(7).
PMID: 39143032
PMC: 11659683.
DOI: 10.1093/jmcb/mjae029.
Evaluation of the Efficacy and Safety of Anifrolumab in Moderate-to-Severe Systemic Lupus Erythematosus.
Cingireddy A, Ramini N, Cingireddy A
Cureus. 2024; 16(7):e63966.
PMID: 39104974
PMC: 11299632.
DOI: 10.7759/cureus.63966.
SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus.
Chen M, Zhang Y, Shi W, Song X, Yang Y, Hou G
Acta Biochim Biophys Sin (Shanghai). 2024; .
PMID: 39099414
PMC: 11693870.
DOI: 10.3724/abbs.2024132.